Pharmaceutical Development CRADA, CMC Pilot Are Among Topics For Manufacturing Subcommittee Meeting
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Manufacturing Subcommittee will also address modernized good manufacturing approaches to process validation and International Conference on Harmonization quality topics.
You may also be interested in...
FDA Plans Pharmaceutical Development Focus Groups With Industry
Focus groups will examine development issues including information bottlenecks, quality systems and preclinical development.
FDA Postpones CMC Pilot Program Deadline
FDA has extended the deadline for its pilot program on the submission of chemistry, manufacturing & controls information in NDAs, according to a notice slated for publication in the Federal Register Sept. 19
FDA Antihypertensive Draft Class Labeling To Be Reviewed By Cardio-Renal Committee
FDA’s proposal for relabeling of antihypertensive agents is based on prior recommendations by the committee that information on cardiovascular outcomes related to blood pressure lowering be included as class labeling.